Shree Ramlakhan Gupta Hospital And Research Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.90 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.95 Cr
- Revenue Growth 3.82%
- Profit Growth -7.55%
- Ebitda 4.05%
- Net Worth 3.95%
- Total Assets 5.88%
About Shree Ramlakhan Gupta Hospital And Research
Shree Ramlakhan Gupta Hospital And Research Pvt. Ltd. (SRGHARPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 November 2005 and has a history of 19 years and two months. Its registered office is in Durg, Chattisgarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹4.95 Cr.
Prashant Gupta, Prafful Gupta, and Pramod Gupta serve as directors at the Company.
Company Details
-
Location
Durg, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110CT2005PTC018128
-
Company No.
018128
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Nov 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Shree Ramlakhan Gupta Hospital And Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Gupta
|
Director | 29-Aug-2016 | Current |
|
Prafful Gupta
|
Director | 21-Nov-2005 | Current |
|
Pramod Gupta
|
Director | 21-Nov-2005 | Current |
Financial Performance of Shree Ramlakhan Gupta Hospital And Research.
Shree Ramlakhan Gupta Hospital And Research Pvt. Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 3.82% increase. The company also saw a slight decrease in profitability, with a 7.55% decrease in profit. The company's net worth moved up by a moderate rise of 3.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Ramlakhan Gupta Hospital And Research?
In 2023, Shree Ramlakhan Gupta Hospital And Research had a promoter holding of 50.33% and a public holding of 49.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹49.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2024 | Others | ₹4.95 Cr | Open |
How Many Employees Work at Shree Ramlakhan Gupta Hospital And Research?
Unlock and access historical data on people associated with Shree Ramlakhan Gupta Hospital And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Ramlakhan Gupta Hospital And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Ramlakhan Gupta Hospital And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.